Chemed (CHE) Net Income towards Common Stockholders (2016 - 2025)
Historic Net Income towards Common Stockholders for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $64.2 million.
- Chemed's Net Income towards Common Stockholders fell 1522.78% to $64.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $278.8 million, marking a year-over-year decrease of 759.84%. This contributed to the annual value of $302.0 million for FY2024, which is 1082.17% up from last year.
- Per Chemed's latest filing, its Net Income towards Common Stockholders stood at $64.2 million for Q3 2025, which was down 1522.78% from $52.5 million recorded in Q2 2025.
- Chemed's Net Income towards Common Stockholders' 5-year high stood at $90.3 million during Q4 2024, with a 5-year trough of $52.5 million in Q2 2025.
- Over the past 5 years, Chemed's median Net Income towards Common Stockholders value was $65.4 million (recorded in 2021), while the average stood at $67.4 million.
- Per our database at Business Quant, Chemed's Net Income towards Common Stockholders crashed by 3439.68% in 2021 and then skyrocketed by 4495.22% in 2023.
- Quarter analysis of 5 years shows Chemed's Net Income towards Common Stockholders stood at $74.6 million in 2021, then dropped by 16.75% to $62.1 million in 2022, then surged by 44.95% to $90.1 million in 2023, then grew by 0.3% to $90.3 million in 2024, then decreased by 28.88% to $64.2 million in 2025.
- Its last three reported values are $64.2 million in Q3 2025, $52.5 million for Q2 2025, and $71.8 million during Q1 2025.